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Abstract 
Background: Specialised sexually transmitted infection (STI) clinics in the Netherlands provide STI care for high-risk 
groups, including female sex workers (FSW), at the clinic and by outreach visiting commercial sex workplaces with 
a permit. The objective was to investigate the STI positivity rate and determinants of an STI diagnosis among FSW 
tested by STI clinics in the Netherlands.
Methods: Sexually transmitted infection clinics report demographic, behavioural and diagnostic information of every 
consultation to the National Institute for Public Health and the Environment. We analysed all consultations of FSW 
between 2006 and 2013. Trends in STI positivity rate (chlamydia, gonorrhoea, infectious syphilis, HIV and hepatitis B) were 
analysed using χ2 for trend and logistic regression was used to analyse determinants associated with an STI diagnosis. 
Differences between consultations at the STI clinic and consultations during outreach were analysed using χ2 tests.
Results: The positivity rate for any STI (overall 9.5 %) was stable from 2006 to 2013. Chlamydia positivity rate (overall 
7.1 %) decreased (p < 0.001) and gonorrhoea positivity rate (overall 2.6 %) increased (p < 0.001). For gonorrhoea, the 
highest positivity rate was found oropharyngeal (2.0 %). Characteristics associated with STI were a younger age [adjusted 
odds ratio (aOR) 0.96, 95 % confidence interval (CI) 0.95–0.97 per year], a previous STI diagnosis (aOR 1.63, 95 % CI 1.38–
1.92) and being notified for an STI by partner notification (aOR 2.61, 95 % CI 2.0–3.40). The STI positivity rate was signifi-
cantly lower among FSW tested at outreach locations (8.6 %) compared to FSW tested at the STI clinic (11.7 %, p < 0.001).
Conclusions: The STI positivity rate among FSW remained stable, but underlying this was a decreasing chlamydia 
trend and an increasing gonorrhoea trend, suggesting a shift in STI risks among FSW over time. Condom use during 
oral sex should be promoted since oropharyngeal gonorrhoea was frequently diagnosed and because of the poten-
tial spread of antimicrobial resistant gonococci.
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Background
The policy concerning commercial sex work in the 
Netherlands is quite different compared to other coun-
tries. In many countries, selling of sex is illegal (Belgium 
[1], South-Africa [2], Canada [3] and most states in the 
United States of America [4]) or the purchase of sex 
is considered a legal offence (Sweden [5]). In the Neth-
erlands, commercial sex work is legal since the brothel 
prohibition was lifted in 2000 [6]. In order to sell sex, 
employers must obtain a permit from the municipali-
ties. The goal of the legalisation was to regulate voluntary 
prostitution, to decrease the amount of involuntary pros-
titution and to improve the social position of sex work-
ers. However, the legislation may have led to an increase 
in illegal prostitution and some argue that the quality of 
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work circumstances of sex workers (legal and illegal) did 
not improve [7].
Female sex workers (FSW) are considered a high-risk 
group for acquisition of sexually transmitted infection 
(STI) [8, 9], due to their social vulnerability and factors 
associated with their work like a history of multiple 
sex partners, inconsistent condom use or co-infection 
with other STI [10, 11]. Even though in the Netherlands 
there were lower STI rates among FSW compared to 
other high-risk groups [12], FSW remain a high-risk 
group for STI transmission to their numerous clients. 
There is a potential for some of these clients to act as a 
bridging population for further spread of STI into the 
general population [13–15]. Because FSW are at high-
risk for STI acquisition and transmission, they are one 
of the target groups for free STI care at specialised STI 
clinics located at public health services throughout 
the Netherlands. These STI clinics provide STI care 
additional to the regular national health services (like 
general practitioners), to reach people who might oth-
erwise not seek STI care timely [16]. The STI clinics are 
funded by the government based on the subsidy regu-
lation Sexual Health [17]. High-risk groups, including 
FSW, can visit these clinics for STI testing. Some STI 
clinics also perform outreach activities for FSW, where 
they routinely visit known commercial sex workplaces 
such as brothels, sex clubs and window-based prosti-
tution in order to provide STI counselling, testing and 
hepatitis B vaccination. There is wide variation between 
STI clinics in the frequency they perform outreach 
activities, varying from weekly to yearly. All workplaces 
with a permit for commercial sex work are obligated 
to provide access to staff of the STI clinic and public 
health services [18]. Although testing is voluntarily, 
FSW are advised to go for STI testing four times a year 
[19].
Although FSW are an important population for STI 
prevention and control, information about the preva-
lence and trends of STI among FSW is limited in the 
Netherlands, compared to other risk groups like young 
people and men having sex with men [20]. In addition, 
little is known about the associated determinants for dif-
ferent STI. More insight into the characteristics of this 
population and the determinants associated with STI 
occurrence might help target STI control. Therefore, the 
objective of our study was to investigate the STI posi-
tivity rate, trends in STI and associated determinants 
among FSW who received STI care by the STI clinics 
(through a visit or by outreach) between 2006 and 2013 
in the Netherlands. Secondary aim was to investigate 
differences between FSW tested through a visit or by 
outreach.
Methods
For this study, we used surveillance data from STI clinics 
who all routinely submit an anonymised predefined set of 
variables (demographics, sexual behaviour, and diagnos-
tic information) of the medical records of each consulta-
tion to the Dutch National Institute of Public Health and 
the Environment (RIVM). Data of the consultations are 
extracted from the medical records and transferred to 
the RIVM using a secured web-based application named 
SOAP [12].
Study population
We included all consultations reported by all STI clin-
ics in the Netherlands between 2006 and 2013 of FSW of 
18 years or older, the legal age to perform sex work in the 
Netherlands. A FSW was defined as a woman who self-
reported to have exchanged sex (vaginal, anal or oral) for 
money or other valuable goods in the 6 months prior to 
the consultation at an STI clinic. During every consulta-
tion, the staff of the STI clinic asks whether the visitor 
had exchanged sex for money or other valuable goods. 
Due to the anonymous character of the available data, 
we cannot retrieve whether the data contains repeated 
consultations of an individual FSW. Therefore, the unit of 
analysis is a consultation.
Data
Variables included in this study were age; year of consul-
tation; ethnicity; previous STI diagnosis (chlamydia, gon-
orrhoea or syphilis) in the last 2 years; ever HIV tested; 
STI symptoms; current STI diagnosis (chlamydia, gon-
orrhoea, syphilis, HIV, hepatitis B); whether the FSW 
was notified for an STI through partner notification 
and condom use at last sexual contact and whether this 
was a casual (paying or non-paying) or steady partner. 
Except for current STI diagnoses, all variables were self-
reported. The categories of the variables are presented 
in Table  1. Due to a policy chance in the registration, 
ethnicity was a combination variable that consisted of 
self-defined ethnicity (from 2006 until 2010) and eth-
nicity based on (parental) country of birth (from 2011 
until 2013) [21]. The variables STI symptoms and part-
ner notification were reported since 2007 and the vari-
able condom use at last sexual contact, and whether this 
contact was a steady or a casual partner were reported 
since 2011. Degree of urbanisation of the attendees’ resi-
dence (five categories based on population density of the 
postal code area, see Table 1), was added to the database 
and analysed for the years 2006–2013 [22]. Because we 
used data that was routinely collected for surveillance 
purposes and data was obtained anonymously, no ethical 
approval was needed.
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Each STI consultation involved laboratory testing and, 
if indicated, medical examination by a physician or spe-
cialised nurse. FSW were offered standard testing for 
chlamydia, gonorrhoea, syphilis and HIV (nation-wide 
opt-out policy since 2007, meaning that FSW are stand-
ard tested for HIV unless they object [23, 24]). As FSW 
are indicated for vaccination against hepatitis B, they 
are screened for hepatitis B. Chlamydia and gonorrhoea 
were tested vaginally, oropharyngeal and, if indicated, 
anorectal. All laboratories used nucleic acid amplified 
tests (NAAT) to diagnose chlamydia and gonorrhoea. 
Culture of Neisseria Gonorrhoeae was sometimes per-
formed in symptomatic cases or in positive NAAT tests. 
Syphilis screening was done using Treponema pallidum 
haemagglutination or Treponema pallidum particle 
agglutination (TPHA/TPPA) tests followed by a vene-
real disease research laboratory (VDRL) test and/or a 
fluorescent treponemal antibody (FTA) test. Infectious 
syphilis included diagnoses of primary and secondary 
syphilis as well as Lues latens recens. HIV was tested by 
enzyme-linked immunosorbent assay (ELISA) combotest 
(antibody/p24 antigen) confirmed by Western Blot test. 
Hepatitis B core antibody was used as screening-test for 
hepatitis B, and if positive hepatitis B surface antigen and 
anti-HBs were tested [25].
Outcome measures and statistical analyses
We calculated the STI positivity rate as the number 
of consultations in which at least one STI (chlamydia, 
gonorrhoea, infectious syphilis, HIV, hepatitis B) was 
diagnosed per 100 consultations. STI specific positivity 
rates were calculated out of those consultations where a 
laboratory test was performed for these specific STI. To 
increase the readability, we will report the STI positivity 
rate among FSW as a percentage when we mean the STI 
positivity rate per 100 consultations. χ2 test for trend was 
performed to assess trends in STI positivity rates over 
time. Positivity rates by anatomic location were calcu-
lated for the years 2008–2013.
Uni- and multivariable logistic regression analyses for 
any STI, chlamydia and gonorrhoea were done for the 
years 2011–2013, because this represents the most recent 
situation and this avoids the break in trend concerning 
the definition of ethnicity. Since it is an explorative study, 
all variables described above were included in the univar-
iable analysis as well as in the multivariable analysis. For 
the outcomes infectious syphilis, HIV and hepatitis B, 
univariable analyses were done for the years 2006–2013, 
due to the small amount of positive diagnoses.
Most STI clinics (22 of 26) performed outreach activi-
ties. Six of those clinics used different coding for the 
consultations at the clinic and outreach consultations. 
In order to investigate whether there were differences 
between FSW tested at the STI clinic and FSW tested 
during outreach, we analysed the characteristics and STI 
positivity rate separately according to location of testing 
using a χ2 test. All analyses were done using SPSS version 
18 with a significance level of p < 0.05.
Results
Characteristics of study population
Between 2006 and 2013, 801,864 consultations were reg-
istered at the STI clinics of which 36,296 (4.5  %) were 
among FSW. Of all consultations among FSW 36,164 
(99.6 %) were 18 years or older. The number of consulta-
tions among FSW aged 18 years or older increased from 
2854 (4.1 % of all consultations) in 2006 to 5877 (4.8 % of 
all consultations) in 2012. In 2013, there were 5770 con-
sultations among FSW (4.3 % of all consultations).
The median age of all FSW was 30  years (interquar-
tile range 24–38  years). In the period 2006–2010 using 
self-defined ethnicity, the greatest number of consulta-
tions were among native Dutch FSW (45.0  %), while in 
the period 2011–2013 using (parental) country of birth, 
the greatest number of consultations were among East-
European FSW (32.8  %). The percentage of FSW ever 
tested for HIV increased from 63.7 % in 2006 to 85.8 % 
in 2013. Of the consultations in 2011–2013 where the last 
sexual contact was a steady partner, a condom was used 
in 15.1 %, while a condom was used in 58.9 % of the con-
sultations where the last sexual contact was a casual (pay-
ing or non-paying) partner (Table 1).
STI positivity rate
The overall STI positivity rate among FSW was 9.5  %, 
and was stable throughout the study period (χ2 for trend, 
p  =  0.5). The positivity rate for chlamydia decreased 
over the years from 8.0  % in 2006 to 6.5  % in 2013 (χ2 
for trend, p =  0.03). For gonorrhoea, the positivity rate 
increased from 2.1  % in 2006 to 3.1  % in 2013 (χ2 for 
trend, p < 0.001). The positivity rate for infectious syphi-
lis decreased from 0.6 % in 2006 to 0.1 % in 2013 (χ2 for 
trend, p  <  0.001). Positivity rates for HIV and hepati-
tis B remained stable [overall 0.1 % (p = 0.27) and 1.0 % 
(p = 0.12) respectively] (Fig. 1).
Table 2 shows the positivity rate by anatomic location 
for chlamydia and gonorrhoea. For chlamydia, the high-
est positivity rate was found anorectal (6.2 %), while for 
gonorrhoea the highest positivity rate was found oro-
pharyngeal (2.0  %). Of the 780 gonorrhoea diagnoses 
between 2008 and 2013, 418 (53.6 %) were diagnosed in 
the oropharynx. This percentage increased from 35.8  % 
in 2008 to 59.0 % in 2013. There was also an increase in 
the percentage of consultations where gonorrhoea was 
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Table 1 Characteristics of female sex workers tested by STI clinics in the Netherlands, 2006–2013
STI sexually transmitted infections
a Ethnicity was based on self-defined ethnicity for 2006–2010 and on (parental) country of birth from 2011–2013
b Diagnosed with chlamydia, gonorrhoea or syphilis in the last 2 years
c Not reported for all years
2006 2007 2008 2009 2010 2011 2012 2013 Total
% % % % % % % % %
Number of consultations (n) 2854 3367 3810 4214 4971 5301 5877 5770 36,164
Age (median) 29 28 29 30 30 30 30 31 30
Ethnicitya
 Native Dutch 51.7 45.1 43.9 44.3 42.6 25.8 29.6 31.6 37.6
 Turkish 0.2 0.2 0.3 0.3 0.2 0.3 0.3 0.3 0.3
 North-African 1.1 1.2 0.8 0.5 0.5 2.5 2.2 2.3 1.5
 Surinamese 1.4 1.3 1.1 1.0 0.6 2.9 3.7 3.6 2.2
 Dutch Antillean 0.7 0.4 0.5 0.2 0.3 1.3 1.8 1.8 1.0
 East-European 15.3 16.4 17.5 21.5 23.2 34.4 33.0 31.0 25.6
 Sub-Saharan African 2.3 2.0 1.8 1.8 2.0 2.6 2.8 2.9 2.3
 Mid-South American 8.5 8.0 9.2 9.3 9.1 10.1 11.8 11.6 10.0
 Other European 13.7 19.5 19.7 16.4 16.6 4.8 5.0 4.9 11.5
 Asian 2.3 2.4 2.9 2.9 3.5 5.8 5.2 6.4 4.3
 Unknown 0.2 0.2 0.3 0.2 0.1 9.5 4.5 3.4 2.8
 Rest 2.5 3.2 2.1 1.7 1.4 0.1 0.1 0.2 1.2
Ever HIV tested
 No 27.5 20.0 16.6 14.4 14.3 12.6 10.7 9.3 14.5
 Yes, positive 0.1 0.2 0.1 0.1 0.1 0.2 0.2 0.3 0.2
 Yes, negative 63.6 72.6 76.1 79.3 80.9 81.7 83.3 85.5 79.3
 Unknown 8.8 7.2 7.2 6.2 4.7 5.5 5.8 4.9 6.1
STI in last 2 yearsb
 No 50.2 55.2 82.9 81.2 82.0 84.2 83.4 81.8 77.5
 Yes 18.3 13.5 11.1 10.5 10.3 7.6 8.4 8.8 10.4
 Unknown 31.6 31.3 6.0 8.3 7.6 8.2 8.2 9.4 12.0
Symptomsc
 No 23.8 71.2 76.5 77.5 76.0 79.6 82.5 66.5
 Yes 15.9 25.2 21.6 21.7 23.5 19.7 17.0 19.0
 Unknown 60.3 3.6 1.9 0.8 0.5 0.7 0.5 15.4
Notified for an STI by partner notificationc
 No 31.6 94.5 97.9 97.9 97.7 96.2 96.5 83.1
 Yes 0.7 1.9 1.3 1.4 2.0 2.1 2.2 1.6
 Unknown 67.7 3.6 0.8 0.6 0.3 1.7 1.3 14.5
Degree of urbanisation
 Very high 33.6 37.5 38.8 36.7 32.4 31.2 29.8 29.7 33.1
 High 15.0 14.6 16.7 15.7 14.4 14.5 13.9 13.9 14.7
 Medium 8.4 7.8 8.6 8.5 7.4 6.3 7.1 7.9 7.6
 Low 3.0 3.6 4.3 4.2 4.1 4.0 4.6 4.0 4.1
 Very low 3.3 2.8 3.4 4.1 4.1 3.8 3.9 3.2 3.6
 Unknown 36.6 33.7 28.1 30.7 37.5 40.1 40.7 41.2 36.8
Condom use at last sexual contact by type of partnerc
 No condom use with steady partner 29.1 15.7 16.8 20.3
 Yes condom use with steady partner 2.8 5.2 2.6 3.6
 No condom use with casual partner 7.6 10.8 9.2 9.2
 Yes condom use with casual partner 51.6 60.4 64.1 58.9
 Unknown 8.9 8.0 7.3 8.1
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tested oropharyngeal; of the 3810 consultations in 2008, 
there were 1870 consultations (49.1 %) where gonorrhoea 
was tested oropharyngeal, in 2013 this was in 4725 of the 
5770 consultations (81.9 %).
Determinants of STI
The multivariable analysis showed that a younger age, 
previous STI diagnosis, and being notified for an STI 




















STI posive Gonorrhoea Chlamydia
Infecous syphilis HIV Hepas B
Fig. 1 STI positivity rate among FSW tested by STI clinics in the Netherlands, 2006–2013
Table 2 Number of tests and positivity rate for chlamydia and gonorrhoea by anatomic location
a All infections diagnosed, including those based on pooled samples and infection with an unknown anatomic location. Infections do not add to the total number of 
diagnoses since infection can occur in multiple locations
2008 2009 2010 2011 2012 2013 Total
Number of consultations 3810 4214 4971 5301 5877 5770 29,943
Chlamydia diagnosesa 254 311 352 408 397 373 2095
Chlamydia urogenital
 n tested 3762 4177 4932 5287 5861 5751 29,770
 n positive (% positive) 237 (6.30) 275 (6.58) 312 (6.33) 345 (6.53) 327 (5.58) 303 (5.27) 1799 (6.04)
Chlamydia oropharyngeal
 n tested 933 1264 1925 3761 4407 4511 16,801
 n positive (% positive) 18 (1.93) 31 (2.45) 51 (2.65) 89 (2.37) 86 (1.95) 67 (1.49) 342 (2.04)
Chlamydia anorectal
 n tested 515 599 697 1163 1754 2343 7071
 n positive (% positive) 38 (7.38) 47 (7.85) 42 (6.03) 80 (6.88) 101 (5.76) 129 (5.51) 437 (6.18)
Gonorrhoea diagnosesa 81 93 120 146 162 178 780
Gonorrhoea urogenital
 n tested 3762 4173 4933 5286 5805 5749 29,708
 n positive (% positive) 57 (1.52) 55 (1.32) 84 (1.70) 94 (1.78) 104 (1.79) 103 (1.79) 497 (1.67)
Gonorrhoea oropharyngeal
 n tested 1870 2339 3305 3869 4519 4725 20,627
 n positive (% positive) 29 (1.55) 37 (1.59) 70 (2.12) 84 (2.17) 93 (2.06) 105 (2.22) 418 (2.03)
Gonorrhoea anorectal
 n tested 1134 1345 1657 2124 2658 2822 11,740
 n positive (% positive) 22 (1.94) 19 (1.41) 18 (1.09) 27 (1.27) 30 (1.13) 29 (1.03) 145 (1.24)
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gonorrhoea, infectious syphilis, HIV and/or hepatitis 
B), chlamydia and gonorrhoea diagnoses (Table 3). FSW 
previously tested HIV negative were significantly less 
likely to be diagnosed with chlamydia compared to FSW 
who were never HIV tested [adjusted odds ratio (aOR) 
0.45, 95 % confidence interval (CI) 0.39–0.53]. An East-
European ethnicity was associated with a higher risk for 
gonorrhoea compared to native Dutch (aOR 1.44, 95  % 
CI 1.19–1.84), but with a lower risk for chlamydia (aOR 
0.79, 95 % CI 0.67–0.93). FSW with a Sub-Saharan Afri-
can, a Mid-South American or a North-African ethnicity 
were also less likely to be diagnosed with chlamydia than 
native Dutch FSW (Table 3).
Infectious syphilis was significantly associated with a 
previous STI diagnosis and several ethnicities (such as 
North-African, Dutch Antilleans and East-European). 
HIV and hepatitis B were more frequently diagnosed 
among Sub-Saharan African and Mid-South American 
ethnicities than among native Dutch. Hepatitis B was sig-
nificantly associated with STI related symptoms. A pre-
vious negative HIV test was associated with a lower risk 
for infectious syphilis, hepatitis B and HIV. Results can 
be found in Additional file 1.
Outreach versus STI clinic
Table 4 shows the results of the comparison between out-
reach consultations and consultations performed at the 
STI clinics. The location of the consultation was known 
for 8606 consultations (24  % of all consultations) of 
which 34.2 % were outreach consultations. The STI posi-
tivity rate was significantly lower for outreach consulta-
tions compared to consultations at the STI clinics (8.6 
and 11.7  % respectively, p  <  0.001). FSW tested during 
outreach were older than FSW tested at the STI clinics 
(median age 32 versus 28 years, p < 0.001) and had more 
frequently a non-Dutch ethnicity (35.5 versus 30.9  %, 
p < 0.001).
Discussion
The number of consultations of FSW as well as the pro-
portion FSW of all STI clinic consultations increased 
during the study period 2006–2013. The overall STI 
positivity rate among FSW who received care by the STI 
clinic remained stable, but there was a decrease in the 
chlamydia positivity rate and an increase in the gonor-
rhoea positivity rate. Determinants significantly associ-
ated with STI positivity were a younger age, a previous 
STI diagnosis and being notified by partner notification.
STI clinics in the Netherlands provide STI care to spe-
cific high-risk groups such as FSW, people below the age 
of 25 years and people with STI-related symptoms [16]. 
Compared to all female STI clinic attendees in 2013 [12], 
FSW were older, less often native Dutch, more often 
ever tested for HIV, more frequently using a condom in 
consultations where the last sexual contact was a casual 
partner and less often diagnosed with an STI (STI posi-
tivity rate of 9.5  % compared to 13.2  %) [12]. The chla-
mydia positivity rate among FSW in 2013 was relatively 
low compared to the chlamydia positivity rate among all 
women who attended these STI clinics (6.5 and 12.2  % 
respectively) [12]. The younger age, which appeared to be 
a risk factor for STI acquisition, and less frequent con-
dom use with a casual partner among all female STI clinic 
attendees compared to FSW could explain this difference. 
Although among FSW the highest chlamydia positiv-
ity rate was found anorectal (5.5 % in 2013), this was still 
lower compared to all women who visited the STI clinic 
(10.2 % in 2013) [12]. The positivity rate of chlamydia that 
we found among FSW was comparable to the chlamydia 
prevalence among FSW in other West-European coun-
tries [26–29]. Countries outside Europe showed higher 
chlamydia prevalence [30, 31]. This could be explained 
by a lack of epidemiological surveillance systems and 
FSW-targeted health services in these countries leading 
to insufficient knowledge about FSW and their STI risk 
and how to target appropriate prevention. Indeed, there 
is a lower condom use with clients among FSW in coun-
tries outside Europe, compared to countries in Western 
Europe [30, 32]. The positivity rate of gonorrhoea in our 
study was comparable to the prevalence among FSW in 
other European countries (around 5  % or less [27, 28, 
33]).
While the positivity rate for chlamydia was lower 
among FSW than among all women who attended the 
STI clinic, the positivity rate for gonorrhoea in our study 
was higher (3.1 % compared to 1.8 %) [12]. This may be 
explained by the high proportion of East-European FSW 
who have a higher gonorrhoea prevalence. Another 
explanation is the higher positivity rate for oropharyn-
geal gonorrhoea among FSW (2.2 % in 2013) than among 
all female STI clinic attendees (1.5 % in 2013), probably 
due to more unsafe oral sex contacts [12, 32]. FSW often 
do not use a condom when performing oral sex, because 
they can charge a higher fee for this service (personal 
communication with health care workers). We did find 
a relative high percentage of condom use in consulta-
tions where the last sexual contact was a casual partner, 
but perhaps this is reported for vaginal/anal intercourse 
only since oral sex might not be considered as ‘sex’ [8, 
15, 34]. Increasing detection of oropharyngeal infections 
may partially explain the increase in gonorrhoea positiv-
ity. Literature shows a decreased susceptibility of gon-
orrhoea for ceftriaxone and cefotaxime among FSW in 
the Netherlands [35]. The threat of emerging resistance 
of gonorrhoea against the current first line treatment, in 
combination with the increasing gonorrhoea positivity 
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Table 3 Uni- and multivariable logistic regression for determinants of STI among FSW, 2011–2013
Any STIa, N = 16,948 Chlamydia, N = 16,933b Gonorrhoea, N = 16,932b
N  
positive
















Age 1624 0.95 (0.95–0.96) 0.96 (0.95–0.97) 1178 0.95 (0.94–0.95) 0.95 (0.95–0.96) 486 0.95 (0.94–0.96) 0.97 (0.96–0.98)
Consultation 
year
1624 0.94 (0.88–1.0) 0.97 (0.91–1.04) 1178 0.91 (0.85–0.98) 0.93 (0.86–1.01) 486 1.06 (0.95–1.19) 1.11 (0.99–1.25)
Ethnicityc
 Native Dutch 483 Reference Reference 385 Reference Reference 124 Reference Reference
 Turkish 5 0.90 (0.36–2.27) 0.66 (0.26–1.68) 4 0.91 (0.33–2.52) 0.61 (0.21–1.73) 2 1.43 (0.35–5.95) 1.37 (0.32–2.55)
 North African 30 0.77 (0.52–1.13) 0.59 (0.40–0.87) 22 0.71 (0.46–1.10) 0.52 (0.33–0.82) 10 1.02 (0.53–1.97) 0.93 (0.48–1.80)
 Surinamese 53 0.92 (0.68–1.24) 0.86 (0.63–1.16) 41 0.89 (0.64–1.24) 0.82 (0.58–1.15) 16 1.09 (0.64–1.85) 1.07 (0.63–1.84)
 Dutch Antil-
leans
41 1.61 (1.14–2.28) 1.30 (0.91–1.85) 31 1.50 (1.02–2.21) 1.15 (0.77–1.72) 12 1.77 (0.97–3.24) 1.36 (0.73–2.54)
 Eastern Euro-
pean
625 1.17 (1.03–1.32) 1.01 (0.88–1.16) 427 0.98 (0.85–1.14) 0.79 (0.67–0.93) 214 1.55 (1.24–1.95) 1.44 (1.19–1.84)
 Sub-Saharan 
African
39 0.84 (0.60–1.19) 0.65 (0.46–0.92) 13 0.34 (0.19–0.60) 0.25 (0.14–0.44) 9 0.76 (0.39–1.51) 0.78 (0.39–1.56)
 Mid-South-
American
128 0.67 (0.55–0.82) 0.84 (0.68–1.04) 85 0.56 (0.44–0.71) 0.72 (0.56–0.93) 37 0.77 (0.53–1.12) 0.99 (0.67–1.46)
 Other Euro-
pean
75 0.91 (0.71–1.18) 0.98 (0.76–1.28) 54 0.82 (0.61–1.10) 0.86 (0.64–1.17) 25 1.20 (0.78–1.86) 1.34 (0.86–2.09)
 Asian 91 0.94 (0.74–1.19) 1.07 (0.84–1.37) 74 0.96 (0.74–1.25) 1.10 (0.84–1.44) 20 0.81 (0.50–1.30) 0.89 (0.55–1.45)
 Unknown 91 0.52 (0.38–0.69) 0.57 (0.42–0.77) 40 0.51 (0.37–0.71) 0.58 (0.41–0.82) 16 0.65 (0.39–1.11) 0.77 (0.45–1.32)
 Rest 3 1.38 (0.41–4.67) 0.98 (0.29–3.36) 2 1.12 (0.26–4.81) 0.80 (0.18–3.48) 1 1.76 (0.24–13.16) 1.24 (0.16–9.53)
STI in last 2 years
 No 1257 Reference Reference 915 Reference Reference 369 Reference Reference
 Yes 206 1.75 (1.49–2.05) 1.63 (1.38–1.92) 154 1.77 (1.48–2.12) 1.58 (1.30–1.91) 62 1.71 (1.30–2.25) 1.41 (1.06–1.89)
 Unknown 161 1.26 (1.06–1.50) 1.13 (0.91–1.39) 109 1.16 (0.95–1.43) 1.05 (0.82–1.35) 55 1.46 (1.09–1.94) 1.11 (0.77–1.59)
Ever HIV tested
 No 325 Reference Reference 256 Reference Reference 79 Reference Reference
 Yes, positive 3 0.39 (0.12–1.26) 0.66 (0.20–2.21) 2 0.33 (0.08–1.39) 0.57 (0.13–2.48) 1 0.58 (0.08–4.30) 1.12 (0.15–8.48)
 Yes, negative 1181 0.42 (0.37–0.48) 0.48 (0.42–0.55) 842 0.39 (0.34–0.45) 0.45 (0.39–0.53) 362 0.58 (0.45–0.75) 0.77 (0.59–1.01)
 Unknown 115 0.67 (0.53–0.84) 0.80 (0.61–1.04) 78 0.57 (0.44–0.75) 0.71 (0.52–0.96) 44 1.12 (0.77–1.63) 1.36 (0.87–2.11)
Symptoms
 No 1174 Reference Reference 854 Reference Reference 341 Reference Reference
 Yes 437 0.55 (0.38–1.75) 1.24 (0.10–1.41) 312 1.50 (1.31–1.72) 1.12 (0.97–1.30) 143 1.70 (1.39–2.07) 1.38 (1.12–1.70)
 Unknown 13 1.64 (0.91–2.95) 1.37 (0.73–2.56) 12 2.13 (1.16–3.92) 2.01 (1.04–3.88) 2 0.83 (0.20–3.37) 0.44 (0.10–1.95)
Notified for an STI by partner notification
 No 1522 Reference Reference 1105 Reference Reference 450 Reference Reference
 Yes 83 2.95 (2.30–3.79) 2.61 (2.0–3.40) 61 2.84 (2.14–3.77) 2.19 (1.61–3.00) 29 3.12 (2.11–4.62) 2.59 (1.70–3.93)
 Unknown 19 1.20 (0.68–1.77) 0.92 (0.54–1.54) 12 0.95 (0.53–1.71) 0.84 (0.44–1.61) 7 1.38 (0.64–2.95) 1.01 (0.44–2.30)
Degree of urbanisation
 Very high 485 Reference Reference 344 Reference Reference 154 Reference Reference
 High 220 0.97 (0.82–1.15) 1.06 (0.89–1.26) 166 1.04 (0.86–1.26) 1.09 (0.89–1.33) 61 0.85 (0.63–1.14) 0.99 (0.73–1.35)
 Medium 113 0.99 (0.80–1.23) 1.10 (0.88–1.38) 85 1.05 (0.82–1.35) 1.12 (0.86–1.45) 31 0.85 (0.58–1.26) 1.02 (0.68–1.54)
 Low 63 0.93 (0.71–1.22) 1.06 (0.80–1.41) 42 0.87 (0.63–1.21) 0.92 (0.65–1.30) 22 1.03 (0.65–1.62) 1.37 (0.86–2.19)
 Very low 49 0.82 (0.60–1.12) 0.96 (0.70–1.31) 39 0.93 (0.66–1.31) 1.07 (0.75–1.52) 9 0.48 (0.24–0.94) 0.61 (0.31–1.21)
 Unknown 694 1.07 (0.95–1.21) 1.07 (0.94–1.21) 502 1.09 (0.95–1.26) 1.10 (0.95–1.28) 209 1.01 (0.82–1.25) 1.01 (0.81–1.27)
 Gonorrhoea 486 121 4.83 (3.89–5.98) 3.77 (3.01–4.72)
 Chlamydia 1178 121 4.83 (3.89–5.98) 3.76 (3.00–4.72)
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rate among FSW raises concerns. Apart from condom 
advice for oral sex, FSW practicing oral sex should always 
be tested oropharyngeal to actively detect oropharyngeal 
infections present.
Female sex workers who were younger, previously diag-
nosed with an STI, or who were notified through partner 
notification, were at higher risk for chlamydia and gonor-
rhoea, which is in line with the literature [20, 36]. While 
East-European FSW were at higher risk for gonorrhoea 
compared with native Dutch FSW, they were at lower risk 
for chlamydia. We found no literature to support this. 
Perhaps this could be explained by the high chlamydia 
prevalence among heterosexual men and women in the 
Netherlands, and/or a higher prevalence of gonorrhoea 
among East-European FSW [12, 32].
The higher STI positivity rate among consultations at 
the clinic compared to consultations performed during 
outreach activities is notable. The Prostitution & Health 
Centre in Amsterdam, which provides care for commer-
cial sex workers, reported comparable results in their 
annual report [37]. There are several possible explana-
tions for the difference in STI positivity rate between 
STI clinic and outreach consultations. First, FSW with 
STI related symptoms or FSW who experienced con-
dom failure actively visit the STI clinic for STI testing. 
Second, during outreach nurses will redirect FSW with 
symptoms to the STI clinic for STI testing and physical 
examination. Third, since only commercial sex work-
places with a permit are obligated to provide the STI 
clinic access, the outreach consultations will mainly be 
among legal FSW. Workplaces with a permit are stimu-
lated by the public health services to promote a safe-sex 
policy and they often have guidelines for condom use 
and STI testing (personal communication with health 
care workers). We expect that FSW without a per-
mit will mainly be tested at the STI clinic, since their 
workplaces are not visited by the STI clinic. We cannot 
exclude that higher STI rates would be found among 
these FSW.
Not all FSW (with or without a permit) will be tested 
at the STI clinic. Reaching FSW currently not seen by 
STI clinics and FSW outside workplaces with a permit 
remains a challenge for public health services. Some STI 
clinics already do internet searches to detect individuals 
who sell sex and some STI clinics try to visit workplaces 
without a permit where selling of sex is suspected in 
order to reach FSW who are currently not seen.
Strengths and limitations
A strength of our study is that we used data from all STI 
clinics in the Netherlands, which means we covered the 
whole FSW population tested by STI clinics. Further-
more, many consultations were included in the database 
and a wide time span was analysed.
A limitation of this study is that most variables (like 
being a FSW, testing history and condom use) were self-
reported which could have led to recall bias and social 
desirability bias. For example, women reporting not to 
Table 3 continued
Any STIa, N = 16,948 Chlamydia, N = 16,933b Gonorrhoea, N = 16,932b
N  
positive
















Condom use at last sexual contact by type of partner
 No condom 
use steady 
partner
368 Reference Reference 279 Reference Reference 95 Reference Reference
 Yes condom 
use steady 
partner
56 0.85 (0.64–1.15) 0.86 (0.64–1.17) 44 0.89 (0.64–1.24) 0.93 (0.66–1.30) 12 0.72 (0.39–1.31) 0.73 (0.40–1.35)
 No condom 
use casual 
partner
200 1.23 (1.02–1.47) 1.19 (0.98–1.44) 153 1.23 (1.00–1.51) 1.21 (0.98–1.50) 53 1.24 (0.88–1.74) 1.14 (0.81–1.63)
 Yes condom 
use casual 
partner
862 0.79 (0.69–0.90) 0.89 (0.78–1.02) 611 0.74 (0.64–0.86) 0.86 (0.73–1.00) 276 1.00 (0.79–1.27) 1.11 (0.86–1.42)
 Unknown 138 0.94 (0.76–1.15) 1.06 (0.85–1.33) 91 0.81 (0.63–1.04) 0.91 (0.70–1.19) 50 1.34 (0.95–1.90) 1.52 (1.04–2.22)
In italics: OR is statistically significant (p < 0.05)
STI sexually transmitted infections, FSW female sex worker, OR odds ratio, aOR adjusted odds ratio, CI confidence interval
a At least one positive diagnose for chlamydia, gonorrhoea, infectious syphilis, HIV or hepatitis B
b Only consultations were included where a related clinical test was done
c Ethnicity was based (parental) country of birth from 2011–2013
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have exchanged sex for money or other valuable goods 
are not categorised as sex workers and thus are not 
included in this study.
Furthermore, we only have information on consulta-
tions and we cannot identify repeated consultations for 
the same FSW. Therefore, odds ratios of determinants 
associated with STI occurrence could be over- or under-
estimated since some consultations referred to the same 
FSW.
Finally, we cannot extrapolate these results to all FSW 
in the Netherlands. This data only contains FSW tested 
by STI clinics, but FSW can also visit their general prac-
titioner for STI testing, conduct a self-test, or visit a 
clinic in their country of origin. This data also cannot be 
extrapolated to FSW who are not tested at all. We would 
expect to find a higher STI positivity rate among these 
FSW, since they are probably not reached by preventive 
public health services. We suggest further research into 
STI prevalence among FSW who are not currently tested 
by STI clinics and how to reach them for counselling and 
primary prevention.
Conclusions
The positivity rate of any STI among FSW remained sta-
ble, but underlying this was a decreasing trend in the 
chlamydia positivity rate and an increasing trend in the 
gonorrhoea positivity rate, suggesting a shift in STI risks 
among FSW over time. Because of the potential trans-
mission of STI, especially gonorrhoea, syphilis and HIV, 
to the general population and because of the increasing 
gonorrhoea positivity rate, preventive counselling and 
increasing awareness of STI risks among FWS remains 
important as well as regular STI testing of FSW. Con-
dom use during oral sex should be promoted since gon-
orrhoea was frequently diagnosed in the oropharynx and 
because of the potential spread of antimicrobial resistant 
gonococci.
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Unknown for 27,558 consultations
STI sexually transmitted infections, FSW female sex worker
STI clinic Outreach P-value
% %
Number of consultations (n) 5560 2946
Age (median) 28 32 <0.001
Ethnicity
 Native Dutch 35.5 30.9 <0.001
 Turkish 0.4 0.0 0.002
 North African 1.7 1.2 0.079
 Surinamese 2.1 1.1 <0.001
 Dutch Antillean 1.3 1.0 0.304
 Eastern European 22.2 26.2 <0.001
 Sub-Saharan African 2.5 1.8 0.028
 Mid-South American 13.5 12.3 0.136
 Other European 14.8 13.7 0.193
 Asian 4.7 10.0 <0.001
 Unknown 1.3 1.6 0.180
 Rest 0.1 0.0 0.077
Previous STI
 No 72.6 80.5 <0.001
 Yes 13.3 3.9 <0.001
 Unknown 14.1 15.6 0.057
Ever HIV tested
 No 16.4 11.2 <0.001
 Yes, positive 0.1 0.0 0.195
 Yes, negative 72.3 74.5 0.027
 Unknown 11.1 14.2 <0.001
Symptoms
 No 59.1 85.1 <0.001
 Yes 22.8 12.4 <0.001
 Unknown 18.1 2.5 <0.001
STI positivity rate
 STI overall 11.7 8.6 <0.001
 Chlamydia 8.4 6.2 <0.001
 Gonorrhoea 3.6 2.5 0.004
 Infectious syphilis 0.4 0.1 0.009
 HIV 0.2 0.1 0.078
 Hepatitis B 1.6 1.5 0.877
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